Atlas Trials

Bioavailability of Nasal Epinephrine

Clinical trial NCT04696822 · COMPLETED

Trial details

NCT number
NCT04696822
Sponsor
Nasus Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anaphylaxis
Start date
2020-11-01
Primary completion
2021-09-28
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.